Greenwood Capital Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-37,703
| Closed | -$3.67M | – | 223 |
|
|
2021
Q1 | $3.67M | Sell |
37,703
-14,173
| -27% | -$1.38M | 0.58% | 60 |
|
|
2020
Q4 | $4.97M | Sell |
51,876
-6,198
| -11% | -$594K | 0.84% | 42 |
|
|
2020
Q3 | $5.58M | Buy |
58,074
+55,641
| +2,287% | +$5.35M | 1.08% | 35 |
|
|
2020
Q2 | $297K | Sell |
2,433
-37
| -1% | -$4.52K | 0.07% | 139 |
|
|
2020
Q1 | $214K | Buy |
2,470
+410
| +20% | +$35.5K | 0.06% | 139 |
|
|
2019
Q4 | $221K | Buy |
+2,060
| New | +$221K | 0.05% | 179 |
|